CalciMedica Future Growth
Future criteria checks 0/6
CalciMedica's earnings are forecast to decline at 9.4% per annum while its annual revenue is expected to grow at 85.7% per year. EPS is expected to grow by 11.4% per annum.
Key information
-9.4%
Earnings growth rate
11.4%
EPS growth rate
| Pharmaceuticals earnings growth | 23.9% |
| Revenue growth rate | 85.7% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 15 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -36 | N/A | N/A | 2 |
| 12/31/2025 | N/A | -30 | N/A | N/A | 3 |
| 12/31/2024 | N/A | -15 | N/A | N/A | 3 |
| 9/30/2024 | N/A | -14 | -20 | -20 | N/A |
| 6/30/2024 | N/A | -13 | -20 | -20 | N/A |
| 3/31/2024 | N/A | -15 | -25 | -25 | N/A |
| 12/31/2023 | N/A | -34 | -26 | -26 | N/A |
| 9/30/2023 | N/A | -30 | -26 | -26 | N/A |
| 6/30/2023 | N/A | -28 | -24 | -23 | N/A |
| 3/31/2023 | N/A | -25 | -13 | -13 | N/A |
| 12/31/2022 | N/A | -9 | -12 | -12 | N/A |
| 9/30/2022 | N/A | -14 | -11 | -11 | N/A |
| 12/31/2021 | N/A | -24 | -21 | -21 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CALC is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CALC is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CALC is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CALC is forecast to have no revenue next year.
High Growth Revenue: CALC is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CALC's Return on Equity is forecast to be high in 3 years time